Filing Details

Accession Number:
0001209191-19-060535
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-12-16 06:21:27
Reporting Period:
2019-12-13
Accepted Time:
2019-12-16 06:21:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1478069 Contrafect Corp CFRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615047 N. David Low 4 Embarcadero Center
Suite 650
San Francisco CA 94111
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2019-12-13 300,000 $0.43 370,550 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The purchase reported in this Form 4 was made on the open market.
  2. The price reported is a weighted average price based on the shares purchased in multiple transactions. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price comprising the average set forth herein.